SHARONBIO

Sharon Bio-Medicine Limited has informed the Exchange about of Newspaper Publication of Audited Financial Results March 31, 2023

Sharon Bio-Medicine Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30 and 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR), please find enclosed the copies of Newspaper advertisement published on February,11th, 2023 given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and nine months ended December, 30, 2022

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Committee of Creditors (CoC) of Sharon Bio-Medicine Limited has approved the resolution plan with requisite majority as per Section 30(4) of the IBC, 2016. Subsequently, the COC approved resolution plan has been filed with Hon'ble National Company Law Tribunal, Mumbai Bench on 22nd November, 2022 for its approval in accordance with Section 30(6) of the IBC, 2016.

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Newspaper Publication of Audited Financial Results

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about Closure of trading window

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about Newspaper Advertisements

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about Closure of trading window

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about Newspaper Advertisements

Intimation of Closure of Trading Window

Subject: Disclosure under Regulation 23(9) of SEBI (LODR) Regulation, 2015 Pursuant to the Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, there were no related party transactions for the half year ended March 31, 2021.Kindly take the above information on your records.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from April 1, 2020 till Forty Eight (48) hours after the declaration of Audited Financial Results of the Company for the year ended March 31, 2020. Currently, the trading is temporarily suspended for capital reduc

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding Submission of disclosure on Related Party Transactions.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from July 1, 2019 till Forty Eight (48) hours after the declaration of Unaudited Financial Results of the Company for the Quarter ended June 30, 2019.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding change in Corporate Office of the company.

Sharon Bio-Medicine Limited has informed the Exchange that the trading window for dealing in the securities of the Company will be closed for the purpose of declaration of financial results of the Company from May 20, 2016 to June 1, 2016.

Sharon Bio-Medicine Limited has informed the Exchange that the Trading Window will be closed for the corporate invent February 10, 2016 To February 16, 2016. The trading window will be open on February 17, 2016

Sharon Bio-Medicine Limited has informed the Exchange that in terms of Code of conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from November 6, 2015 to November 16, 2015. The trading window will open on November 17, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that in terms of Code of conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed from August 27, 2015 to September 1, 2015. The trading window will open on September 2, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that In terms of Code of conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulatiors, 2015. All Directors/ Officers / Designated employees of the Company are advised not to deal in shares of the Company during the trading window is closed from June 8, 2015 to June 12, 2015 on event of allotment of Equity shares in exchange of warrants. The trading window will open on June 15, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that the code of conduct adopted by the Board of Directors in their meeting held on May 27, 2015 under SEBI {(Prohibition of insider Trading) Reg, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that the trading window will be closed from May 5, 2015 to May 15, 2015 (both days inclusive).

Sharon Bio-Medicine Limited has informed the Exchange that the Trading Window will be closed from February 3, 2015 to February 16, 2015 (both days inclusive).

Sharon Bio-Medicine Limited has informed the Exchange that in terms of Code of conduct adopted by the Company under Regulation 12 of SEBI (Prohibition of Insider Trading) Regulation, 1992 and with reference to circular letter dated February 03, 2014 the Trading Window will be closed during the mentioned period for the corporate event : Window closure period : November 10, 2014 to November 14, 2014. Further it is informed that the Trading Window will open on November 15, 2014.